UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043274
Receipt number R000049390
Scientific Title Clinical Characteristics and Treatment Outcomes of Severe Asthma Patients with a History of Multiple Biologic Drugs Use
Date of disclosure of the study information 2021/02/07
Last modified on 2021/02/07 18:37:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical Characteristics and Treatment Outcomes of Severe Asthma Patients with a History of Multiple Biologic Drugs Use

Acronym

Clinical Characteristics and Treatment Outcomes of Severe Asthma Patients with a History of Multiple Biologic Drugs Use

Scientific Title

Clinical Characteristics and Treatment Outcomes of Severe Asthma Patients with a History of Multiple Biologic Drugs Use

Scientific Title:Acronym

Clinical Characteristics and Treatment Outcomes of Severe Asthma Patients with a History of Multiple Biologic Drugs Use

Region

Japan


Condition

Condition

asthma

Classification by specialty

Pneumology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

we aimed to elucidate the clinical characteristics and outcomes of severe asthma patients who used biologic drug.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Change of asthma control test after the latest biologic drug use.

Key secondary outcomes

Annual exacerbation rate, oral corticosteroid dose


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Severe asthma patients (equivalent to guideline steps 4 or 5, according 18 to the Global Initiative for Asthma 2019) who received biologic drug for the treatment of asthma

Key exclusion criteria

History of immunodeficiency or malignancy

Target sample size

105


Research contact person

Name of lead principal investigator

1st name Akaba
Middle name
Last name Tomohiro

Organization

Tokyo Women's Medical University

Division name

Department of respiratory medicine

Zip code

162-0054

Address

8-1, Kawada-cho, Shinjuku-ku, Tokyo

TEL

03-3353-8111

Email

akaba.tomohiro@twmu.ac.jp


Public contact

Name of contact person

1st name Akaba
Middle name
Last name Tomohiro

Organization

Tokyo Women's Medical University

Division name

Department of respiratory medicine

Zip code

162-0054

Address

8-1, Kawada-cho, Shinjuku-ku, Tokyo

TEL

03-3353-8111

Homepage URL


Email

akaba.tomohiro@twmu.ac.jp


Sponsor or person

Institute

Tokyo Women's Medical University

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tokyo women's medical university

Address

Kawada-cho 8-1, shinjuku-ku, Tokyo, Japan

Tel

03-3353-8111

Email

rinri.b@twmu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 02 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

105

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 05 Month 19 Day

Date of IRB

2020 Year 05 Month 19 Day

Anticipated trial start date

2020 Year 05 Month 19 Day

Last follow-up date

2020 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Observational study


Management information

Registered date

2021 Year 02 Month 07 Day

Last modified on

2021 Year 02 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049390


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name